Fibrinogen variant BβD432A has normal polymerization but does not bind knob "B"

Blood

Volumn 113, Issue 18, 2009, Pages 4425-4430

  Bowley, Sheryl R ^a   Lord, Susan T ^a,b  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 13A; FIBRINOGEN; FIBRINOGEN VARIANT; THROMBIN; BATROXOBIN; BBETA FIBRINOGEN; BLOOD CLOTTING FACTOR 13; CALCIUM; CROSS LINKING REAGENT; FIBRIN; FIBRINOLYTIC AGENT; GLYCYL HISTIDYL ARGINYL PROLINE; GLYCYL-HISTIDYL-ARGINYL-PROLINE; HEMOSTATIC AGENT; OLIGOPEPTIDE; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; BLOOD CLOTTING; CALCIUM BINDING; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CRYSTAL STRUCTURE; PRIORITY JOURNAL; PROTEIN POLYMERIZATION; SCANNING ELECTRON MICROSCOPY; STRUCTURE ACTIVITY RELATION; X RAY DIFFRACTION; ANIMAL; BINDING SITE; CELL CULTURE; CHEMISTRY; CHO CELL; CRICETULUS; GENETICS; HAMSTER; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE; X RAY CRYSTALLOGRAPHY;

ANIMALS; BATROXOBIN; BINDING SITES; CALCIUM; CELLS, CULTURED; CHO CELLS; CRICETINAE; CRICETULUS; CROSS-LINKING REAGENTS; CRYSTALLOGRAPHY, X-RAY; FACTOR XIII; FIBRIN; FIBRINOGEN; FIBRINOLYTIC AGENTS; HEMOSTATICS; HUMANS; MICROSCOPY, ELECTRON, SCANNING; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; THROMBIN;

EID: 66149110352     PISSN: 00064971     EISSN: 15280020     Source Type: None    
DOI: 10.1182/blood-2008-09-178178     Document Type: Article

References (39)

1. Weisel JW. Fibrinogen and fibrin. Adv Protein Chem. 2005;70:247-299.
2. Doolittle RF. Fibrinogen and fibrin. Annu Rev Biochem. 1984;53:195-229.
3. Spraggon G, Everse SJ, Doolittle RF. Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin. Nature. 1997;389:455-462. (Pubitemid 27435313)
4. Pratt KP, Cote HC, Chung DW, Stenkamp RE, Davie EW. The primary fibrin polymerization pocket: three-dimensional structure of a 30-kDa C-terminal gamma chain fragment complexed with the peptide Gly-Pro-Arg-Pro. Proc Natl Acad Sci U S A. 1997;94:7176-7181. (Pubitemid 27345288)
5. Kostelansky MS, Betts L, Gorkun OV, Lord ST. 2.8 A crystal structures of recombinant fibrinogen fragment D with and without two peptide ligands: GHRP binding to the "b" site disrupts its nearby calcium-binding site. Biochemistry. 2002;41: 12124-12132.
6. Everse SJ, Spraggon G, Veerapandian L, Riley M, Doolittle RF. Crystal structure of fragment double-D from human fibrin with two different bound ligands. Biochemistry. 1998;37:8637-8642. (Pubitemid 28299601)
7. Okumura N, Furihata K, Terasawa F, Nakagoshi R, Ueno I, Katsuyama T. Fibrinogen Matsumoto I: a gamma 364 Asp→His (GAT→CAT) substitution associated with defective fibrin polymerization. Thromb Haemost. 1996;75:887-891.
8. Bentolila S, Samama MM, Conard J, Horellou MH, Ffrench P. [Association of dysfibrinogenemia and thrombosis: apropos of a family (Fibrinogen Melun) and review of the literature]. Ann Med Interne (Paris). 1995;146:575-580. (Pubitemid 26124469)
9. Okumura N, Terasawa F, Haneishi A, et al. B:b interactions are essential for polymerization of variant fibrinogens with impaired holes 'a'. J Thromb Haemost. 2007;5:2352-2359.
10. Kostelansky MS, Bolliger-Stucki B, Betts L, Gorkun OV, Lord ST. B beta Glu397 and B beta Asp398 but not B beta Asp432 are required for "B:b" interactions. Biochemistry. 2004;43:2465-2474.
11. Bowley SR, Merenbloom BK, Okumura N, et al. Polymerization-defective fibrinogen variant gammaD364A binds knob "A" peptide mimic. Biochemistry. 2008;47:8607-8613.
12. Lord ST, Strickland E, Jayjock E. Strategy for recombinant multichain protein synthesis: fibrinogen B beta-chain variants as thrombin substrates. Biochemistry. 1996;35:2342-2348. (Pubitemid 26071667)
13. Lord ST, Binnie CG, Hettasch JM, Strickland E. Purification and characterization of recombinant human fibrinogen. Blood Coagul Fibrinolysis. 1993;4:55-59. (Pubitemid 23064916)
14. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
15. Everse SJ, Pelletier H, Doolittle RF. Crystallization of fragment D from human fibrinogen. Protein Sci. 1995;4:1013-1016.
16. Otwinowski Z, Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 1997;276:307-326. (Pubitemid 27085611)
17. Vagin A, Teplyakov A. MOLREP: an automated program for molecular replacement. J Appl Cryst. 1997;30:1022-1025. (Pubitemid 127485985)
18. CCP4. Acta Crystallogr D. 1994;50:760-763.
19. Murshudov GN, Vagin AA, Dodson EJ. Refinement of macromolecular structures by the maximum- likelihood method. Acta Cryst. 1997;D53: 240-255. (Pubitemid 27235885)
20. Jones TA, Zou JY, Cowan SW, Kjeldgaard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A. 1991;47:110-119.
21. Read RJ. Improved Fourier coefficients for maps using phases from partial structures with errors. Acta Crystallogr A. 1986;42:140-149.
22. Winn M, Isupov M, Marshudov GN. Use of TLS parameters to model anisotropic displacements in macromolecular refinement. Acta Cryst. 2001; D57:122-133. (Pubitemid 32062682)
23. Protein Data Bank. http://www.rcsb.org. Accessed November 2008.
24. Mullin JL, Gorkun OV, Lord ST. Decreased lateral aggregation of a variant recombinant fibrinogen provides insight into the polymerization mechanism. Biochemistry. 2000;39:9843-9849.
25. Everse SJ, Spraggon G, Veerapandian L, Doolittle RF. Conformational changes in fragments D and double-D from human fibrin(ogen) upon binding the peptide ligand Gly-His-Arg-Proamide. Biochemistry. 1999;38:2941-2946. (Pubitemid 129501348)
26. Kostelansky MS, Lounes KC, Ping LF, Dickerson SK, Gorkun OV, Lord ST. Probing the gamma2 calcium-binding site: studies with gammaD298,301A fibrinogen reveal changes in the gamma294-301 loop that alter the integrity of the "a" polymerization site. Biochemistry. 2007; 46:5114-5123.
27. Lounes KC, Ping L, Gorkun OV, Lord ST. Analysis of engineered fibrinogen variants suggests that an additional site mediates platelet aggregation and that "B-b" interactions have a role in protofibril formation. Biochemistry. 2002;41:5291-5299.
28. Geer CB, Tripathy A, Schoenfisch MH, Lord ST, Gorkun OV. Role of 'B-b' knob-hole interactions in fibrin binding to adsorbed fibrinogen. J Thromb Haemost. 2007;5:2344-2351.
29. Brummel KE, Butenas S, Mann KG. An integrated study of fibrinogen during blood coagulation. J Biol Chem. 1999;274:22862-22870. (Pubitemid 129529312)
30. Blombäck B, Hessel B, Hogg D, Therkildsen L. A two-step fibrinogen-fibrin transition in blood coagulation. Nature. 1978;275:501-505. (Pubitemid 9020557)
31. Weisel JW. Fibrin assembly: lateral aggregation and the role of the two pairs of fibrinopeptides. Biophys J. 1986;50:1079-1093.
32. Hantgan RR, Hermans J. Assembly of fibrin: a light scattering study. J Biol Chem. 1979;254: 11272-11281. (Pubitemid 10136141)
33. Laudano AP, Doolittle RF. Synthetic peptide derivatives that bind to fibrinogen and prevent the polymerization of fibrin monomers. Proc Natl Acad Sci U S A. 1978;75:3085-3089.
34. Furlan M, Rupp C, Beck EA, Svendsen L. Effect of calcium and synthetic peptides on fibrin polymerization. Thromb Haemost. 1982;47:118-121.
35. Doolittle RF, Pandi L. Probing the beta-chain hole of fibrinogen with synthetic peptides that differ at their amino termini. Biochemistry. 2007;46: 10033-10038. (Pubitemid 47378594)
36. Litvinov RI, Yakovlev S, Tsurupa G, Gorkun OV, Medved L, Weisel JW. Direct evidence for specific interactions of the fibrinogen alphaC-domains with the central E region and with each other. Biochemistry. 2007;46:9133-9142. (Pubitemid 47237388)
37. Gorkun OV, Veklich YI, Medved LV, Henschen AH, Weisel JW. Role of the alpha C domains of fibrin in clot formation. Biochemistry. 1994;33: 6986-6997. (Pubitemid 2102270)
38. Doolittle RF, Pandi L. Binding of synthetic B knobs to fibrinogen changes the character of fi- brin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin. Biochemistry. 2006;45:2657-2667. (Pubitemid 43297325)
39. Bowley SR, Gorkun OV, Lord ST. Fibrinogen variant BβD432A: new insights on the role of "B:b" interactions in fibrin polymerization. J Thromb Haemost. 2007;5(suppl 2):O-S-048.